FI912203A0 - Muteiner av den granylocyt-kolonier stimulerande faktorn (g-csf). - Google Patents

Muteiner av den granylocyt-kolonier stimulerande faktorn (g-csf).

Info

Publication number
FI912203A0
FI912203A0 FI912203A FI912203A FI912203A0 FI 912203 A0 FI912203 A0 FI 912203A0 FI 912203 A FI912203 A FI 912203A FI 912203 A FI912203 A FI 912203A FI 912203 A0 FI912203 A0 FI 912203A0
Authority
FI
Finland
Prior art keywords
stimulerande
muteiner
kolonier
granylocyt
faktorn
Prior art date
Application number
FI912203A
Other languages
English (en)
Other versions
FI912203A (fi
Inventor
Guenther Schumacher
Carola Dony
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI912203A0 publication Critical patent/FI912203A0/fi
Publication of FI912203A publication Critical patent/FI912203A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K26/00—Working by laser beam, e.g. welding, cutting or boring
    • B23K26/351—Working by laser beam, e.g. welding, cutting or boring for trimming or tuning of electrical components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Plasma & Fusion (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI912203A 1990-05-08 1991-05-07 Muteiner av den granylocyt-kolonier stimulerande faktorn (g-csf). FI912203A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014750A DE4014750A1 (de) 1990-05-08 1990-05-08 Muteine des granulozyten-stimulierenden faktors (g-csf)

Publications (2)

Publication Number Publication Date
FI912203A0 true FI912203A0 (fi) 1991-05-07
FI912203A FI912203A (fi) 1991-11-09

Family

ID=6405959

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912203A FI912203A (fi) 1990-05-08 1991-05-07 Muteiner av den granylocyt-kolonier stimulerande faktorn (g-csf).

Country Status (17)

Country Link
EP (1) EP0456200A1 (fi)
JP (1) JPH04225998A (fi)
KR (1) KR940000757B1 (fi)
CN (1) CN1057862A (fi)
AU (1) AU631312B2 (fi)
CA (1) CA2041439A1 (fi)
CS (1) CS133391A3 (fi)
DE (1) DE4014750A1 (fi)
FI (1) FI912203A (fi)
HU (1) HUT58801A (fi)
IE (1) IE911359A1 (fi)
IL (1) IL98070A0 (fi)
NO (1) NO911786L (fi)
NZ (1) NZ237975A (fi)
PL (1) PL290166A1 (fi)
PT (1) PT97611A (fi)
ZA (1) ZA913430B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718893A (en) * 1984-04-15 1998-02-17 Foster; Preston F. Use of G-CSF to reduce acute rejection
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US5536495A (en) * 1994-04-15 1996-07-16 Foster; Preston F. Use of G-CSF to reduce acute rejection
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
KR100440460B1 (ko) * 1998-07-08 2004-10-08 주식회사유한양행 인체 과립구 콜로니 자극인자의 유전자, 재조합 벡터 및 형질 전환체 및 그들을 이용한 인체 과립구 콜로니 자극인자의 제조방법
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
DE19860801A1 (de) * 1998-12-30 2000-07-06 Rhein Biotech Proz & Prod Gmbh Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor)
ATE348883T1 (de) * 2000-09-08 2007-01-15 Massachusetts Inst Technology Zusammensetzungen und verfahren mit analogen von g-csf
WO2002069232A2 (en) 2001-02-19 2002-09-06 Merck Patent Gmbh Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
JP4444652B2 (ja) 2001-07-11 2010-03-31 マキシゲン・ホールディングズ・リミテッド Ｇ−ｃｓｆ結合体
US7785601B2 (en) 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7695723B2 (en) 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
DE102004041639A1 (de) 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies
WO2006055260A2 (en) 2004-11-05 2006-05-26 Northwestern University Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders
JP5137821B2 (ja) 2005-06-01 2013-02-06 マキシジェン， インコーポレイテッド Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
DE102006009437A1 (de) 2006-03-01 2007-09-13 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
EP2581441A1 (en) 2007-08-09 2013-04-17 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
PT2197919E (pt) 2007-08-27 2014-07-17 Ratiopharm Gmbh Formulação líquida de conjugado de g-csf
EP2076243B9 (de) 2007-08-27 2015-01-14 ratiopharm GmbH Flüssigformulierung von g-csf
DE102007040932A1 (de) 2007-08-27 2009-03-05 Biogenerix Ag Flüssigformulierung von G-CSF
US8758761B2 (en) 2007-09-30 2014-06-24 University Of Florida Research Foundation, Inc. Combination therapies for treating type 1 diabetes
RU2573909C2 (ru) 2010-03-04 2016-01-27 Пфенекс Инк. Способ получения растворимого рекомбинантного белка интерферона без денатурирования
AU2011235210B2 (en) 2010-04-01 2015-07-16 Pfenex Inc. Methods for G-CSF production in a Pseudomonas host cell
EP2399572A1 (en) 2010-06-22 2011-12-28 Sandoz AG Long-term storage of non-glycosylated recombinant human G-CSF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06102021B2 (ja) * 1985-12-03 1994-12-14 中外製薬株式会社 新規なポリペプチド
JPS63500636A (ja) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
EP0256843A1 (en) * 1986-08-11 1988-02-24 Cetus Corporation Expression of g-csf and muteins thereof and their use
WO1988003173A2 (en) * 1986-10-24 1988-05-05 Cetus Corporation New forms of colony stimulating factor-1
NO176799C (no) * 1986-12-23 1995-05-31 Kyowa Hakko Kogyo Kk DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid

Also Published As

Publication number Publication date
EP0456200A1 (de) 1991-11-13
IL98070A0 (en) 1992-06-21
AU631312B2 (en) 1992-11-19
CA2041439A1 (en) 1991-11-09
AU7638091A (en) 1991-11-14
NO911786L (no) 1991-11-11
NO911786D0 (no) 1991-05-07
HU911529D0 (en) 1991-11-28
IE911359A1 (en) 1991-11-20
HUT58801A (en) 1992-03-30
PL290166A1 (en) 1992-01-13
NZ237975A (en) 1992-09-25
FI912203A (fi) 1991-11-09
JPH04225998A (ja) 1992-08-14
KR910020033A (ko) 1991-12-19
DE4014750A1 (de) 1991-11-14
CN1057862A (zh) 1992-01-15
CS133391A3 (en) 1992-01-15
KR940000757B1 (ko) 1994-01-29
PT97611A (pt) 1992-03-31
ZA913430B (en) 1992-02-26

Similar Documents

Publication Publication Date Title
FI912203A (fi) Muteiner av den granylocyt-kolonier stimulerande faktorn (g-csf).
FI875710A0 (fi) Vindturbin och saekerhetsanordningar av den.
FI913817A (fi) Nya utfoeringsformer av den huvudsakliga hiv-neutraliserande determinanten.
FI910856A0 (fi) Foerfarande foer reglering av stroemriktningar i en pappersmaskins inloppslaoda.
FI905959A0 (fi) Blaos- och luftkonditioneringsanordning foer en svaengd cylindergrupp i torkningspartiet av en pappersmaskin.
FI905896A (fi) Formningsgapsarrangemang i en dubbelviraformare av en pappersmaskin.
FI912030A0 (fi) Utbyte av sikten i en kokare.
FI896174A0 (fi) Spektriskt effektivt foerfarande foer foermedlande av den informationssignal.
FI906349A0 (fi) Regleranordning foer den oevre laeppbalken av en inloppslaoda.
FI923184A (fi) Nedisningsskydd i form av en belaeggning.
FI910657A (fi) Minskning av synligt ljus i en icke-synligt kemiskt ljus producerande anordning.
FI916172A0 (fi) Foerfarande foer (bland-)polymeri- sering av etylen.
FI915299A0 (fi) Processarrangemang foer den korta cirkulationen i en pappersmaskin.
FI914005A0 (fi) Foerbaettrat foerfarande och kompositioner foer att foerhindra den aminoglykosida nefrotoxiciteten.
FI911532A0 (fi) Foerfarande foer minskning av detektheten i mycket tunna skikt.
FI914034A0 (fi) Skumgummimadrass och framstaellning av den.
FI900345A (fi) Vaermningsapparat foer uppvaermning av vaetskan i cisternen (tanken).
FI921955A0 (fi) Foerbaettrad foderblandning och foerfarande foer dosering av den.
FI884649A0 (fi) Regleranordning foer den oevre laeppbalken av en pappersmaskins inloppslaoda.
FI902716A0 (fi) Arrangemang foer vaegning av en last.
FI905598A (fi) Foerfarande foer bestaemning av ingediensinhalter av luftkrets i oenskad riktning.
FI901366A0 (fi) Anordning foer tillvaratagande av lyftkraft i vaetska.
FI900868A0 (fi) Utjaemnare av dragkraft i vaeghyvel.
FI903005A0 (fi) Turbulensgenerator i inloppslaodan av en pappersmaskin.
FI901880A0 (fi) Anordning avsedd foer maetning av en inhalerbar laekemedelsdos i pulverform.

Legal Events

Date Code Title Description
FD Application lapsed